Anthera Pharmaceuticals Inc (ANTH) Financial Statements (2023 and Earlier)

Company Profile

Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B
HAYWARD, CA 94545
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,19620,84346,9512,63925,94624,753
Cash and cash equivalents2,19620,84346,9512,63925,94619,431
Short-term investments     5,322
Receivables  326   
Prepaid expense and other current assets426
Other undisclosed current assets9951,865585383358 
Total current assets:3,19122,70847,8623,02226,30425,179
Noncurrent Assets
Property, plant and equipment4827632634688121,150
Regulated entity, other noncurrent assets     116
Restricted cash and investments    10,000 
Other noncurrent assets    301
Total noncurrent assets:48276326346811,1131,266
TOTAL ASSETS:3,67323,47148,1253,49037,41726,445
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,9266,7406,9533,5124,3126,047
Accounts payable1,8324,7825,2592,2323,5195,206
Accrued liabilities1,06611398211474497
Employee-related liabilities281,8451,5961,069319344
Debt    2,7779,329
Deferred revenue and credits  138   
Other liabilities   1,000  
Other undisclosed current liabilities1,7853,8841,3771,2394723,374
Total current liabilities:4,71110,6248,4685,7517,56118,750
Noncurrent Liabilities
Long-term debt and lease obligation    15,09811,221
Long-term debt, excluding current maturities    15,09811,221
Liabilities, other than long-term debt4,457     
Other liabilities4,457     
Total noncurrent liabilities:4,457   15,09811,221
Total liabilities:9,16810,6248,4685,75122,65929,971
Stockholders' equity
Stockholders' equity attributable to parent, including:(5,495)12,47039,657(2,261)14,758(3,526)
Common stock144640231979
Additional paid in capital428,586411,364391,648314,527301,946256,790
Accumulated other comprehensive loss     (17)
Accumulated deficit(434,428)(407,554)(352,031)(316,811)  
Other undisclosed stockholders' equity attributable to parent3338,614  (287,207)(260,378)
Other undisclosed stockholders' equity 377    
Total stockholders' equity:(5,495)12,84739,657(2,261)14,758(3,526)
TOTAL LIABILITIES AND EQUITY:3,67323,47148,1253,49037,41726,445

Income Statement (P&L) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
 1453,185  245
Gross profit: 1453,185  245
Operating expenses(36,432)(57,322)(38,428)(28,459)(28,247)(55,934)
Other undisclosed operating loss     (245)
Operating loss:(36,432)(57,177)(35,243)(28,459)(28,247)(55,934)
Nonoperating income (expense)9,5581,65423 (2,614)(3,465)
Other nonoperating income (expense)(85)(90)23   
Interest and debt expense   (1,049)(2,599)(3,354)
Net loss:(26,874)(55,523)(35,220)(29,508)(33,460)(62,753)
Other undisclosed net income (loss) attributable to parent   (96)2,5993,354
Net loss attributable to parent:(26,874)(55,523)(35,220)(29,604)(30,861)(59,399)
Other undisclosed net loss available to common stockholders, basic(2,503)(10,914)    
Net loss available to common stockholders, diluted:(29,377)(66,437)(35,220)(29,604)(30,861)(59,399)

Comprehensive Income ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(26,874)(55,523)(35,220)(29,508)(33,460)(62,753)
Comprehensive loss:(26,874)(55,523)(35,220)(29,508)(33,460)(62,753)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (96)2,6163,366
Comprehensive loss, net of tax, attributable to parent:(26,874)(55,523)(35,220)(29,604)(30,844)(59,387)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: